Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain
Condition: Severe Eosinophilic Asthma Intervention: Sponsor: AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials